Laxido Paediatric Plain

Macrogol 3350, Sodium Hydrogen Carbonate, Potassium Chloride and Sodium Chloride, the active ingredients in Laxido Paediatric Plain, are a laxative presented as an oral powder for oral administration. The formulation is intended for children and works by retaining water in the intestinal lumen to soften stool and promote regular bowel movements in pediatric constipation.

GNH USA supplies Laxido Paediatric Plain as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing EU‑origin products that meet stringent quality standards.

Laxido Paediatric Plain, an osmotic laxative, is used to manage constipation and related bowel disorders in children.

Functional constipation: helps restore regular bowel movements by softening stools. Encopresis secondary to constipation: reduces stool hardness and frequency of soiling. Fecal impaction prevention: maintains stool softness to avoid blockage in pediatric patients.

Laxido Paediatric Plain may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal bloating - Flatulence - Nausea - Diarrhea

Serious or Rare Side Effects: - Severe electrolyte imbalance - Dehydration - Allergic reaction (rash, itching, swelling) - Persistent abdominal pain

When using Laxido Paediatric Plain, certain precautions should be observed to ensure safety and effectiveness.

Assess electrolyte status: check baseline sodium, potassium and chloride levels before initiating therapy. Use under medical supervision: dosage should be individualized by a healthcare professional. Adjust for renal impairment: monitor kidney function and modify dose if necessary. Monitor for dehydration: ensure adequate fluid intake during treatment. Avoid in intestinal obstruction: contraindicated in patients with known bowel blockage. Store at ambient temperature: keep in original packaging, protect from moisture and heat.

Laxido Paediatric Plain can interact with other medicines, affecting electrolyte balance or gastrointestinal function.

Major Interactions (Avoid): - Concurrent use with other osmotic laxatives: risk of severe electrolyte disturbances. - Combination with loop diuretics: may exacerbate potassium loss and dehydration.

Moderate Interactions (Monitor Closely): - Antacids containing magnesium or aluminum: may alter absorption of the polymer. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): increase risk of gastrointestinal irritation. - Mineral supplements (e.g., calcium, iron): can affect stool consistency and electrolyte levels.